Access

Outlook

Nature 449, 180-182 (13 September 2007) | doi:10.1038/449180a; Published online 12 September 2007

Open Innovation Challenges

naturejobs

Neglected Diseases The road to recovery

Carlos M. Morel1, José R. Carvalheiro2, Carmen N. P. Romero3, Eduardo A. Costa4 & Paulo M. Buss5

Top

Brazil urgently needs to improve infrastructure for generating pharmaceuticals to alleviate the plight of its poor and marginalized populations, say Carlos M. Morel et al.

Despite Brazil's strength in basic scientific and medical research, a large proportion of the population still suffers from ill health. Diseases such as tuberculosis and leprosy are highly prevalent in poor populations, and about 46,000 people die each year from infectious diseases.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Protozoan genomics for drug discovery

Nature Biotechnology News and Views (01 Sep 2005)